Your browser doesn't support javascript.
loading
EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays.
Pihl, Susanne; van der Strate, Barry Wa; Golob, Michaela; Ryding, Janka; Vermet, Laurent; Jaitner, Birgit; Goodman, Joanne; Timmerman, Philip.
Affiliation
  • Pihl S; Ascendis Pharma A/S, Copenhagen, Denmark.
  • van der Strate BW; University Medical Center Groningen, The Netherlands.
  • Golob M; Nuvisan GmbH, Grafing, Germany.
  • Ryding J; Svar Life Science Wieslab AB, Malmoe, Sweden.
  • Vermet L; Sanofi Research & Development, Montpellier, France.
  • Jaitner B; Novartis Pharma AG, Basel, Switzerland.
  • Goodman J; AstraZeneca, Cambridge, UK.
  • Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, 1000 Brussels, Belgium.
Bioanalysis ; 11(19): 1787-1798, 2019 10.
Article in En | MEDLINE | ID: mdl-31657235

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Hypersensitivity / Antibodies Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Bioanalysis Year: 2019 Document type: Article Affiliation country: Denmark

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Hypersensitivity / Antibodies Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Bioanalysis Year: 2019 Document type: Article Affiliation country: Denmark